Gemcitabine and docetaxel as second-line chemotherapy in elderly patients with metastatic urothelial carcinoma: a retrospective analysis

Taku Naiki,1 Keitaro Iida,1 Toshiki Etani,1 Takashi Nagai,2 Yutaro Tanaka,1 Yosuke Sugiyama,3 Ryosuke Ando,1 Shuzo Hamamoto,1 Rika Banno,4 Daisuke Nagata,4 Noriyasu Kawai,1 Takahiro Yasui1 1Department of Nephro-Urology, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan; 2Dep...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Management and Research
Main Authors: Naiki T, Iida K, Etani T, Nagai T, Tanaka Y, Sugiyama Y, Ando R, Hamamoto S, Banno R, Nagata D, Kawai N, Yasui T
Formato: Artigo
Publicado: Dove Medical Press 2018-09-01
Assuntos:
Gemcitabine and docetaxel
Elderly patients
Second-line
Metastatic urothelial carcinoma
Acceso en liña:https://www.dovepress.com/gemcitabine-and-docetaxel-as-second-line-chemotherapy-in-elderly-patie-peer-reviewed-article-CMAR
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Internet

https://www.dovepress.com/gemcitabine-and-docetaxel-as-second-line-chemotherapy-in-elderly-patie-peer-reviewed-article-CMAR

Títulos similares